Mecure Industries PLC (NGX:MECURE)

Nigeria flag Nigeria · Delayed Price · Currency is NGN
75.85
-8.40 (-9.97%)
At close: Feb 27, 2026
504.38%
Market Cap 303.40B
Revenue (ttm) 77.69B
Net Income (ttm) 6.46B
Shares Out 4.00B
EPS (ttm) 1.62
PE Ratio 46.82
Forward PE n/a
Dividend 0.15 (0.20%)
Ex-Dividend Date Apr 22, 2025
Volume 158,695
Average Volume 149,440
Open 75.85
Previous Close 84.25
Day's Range 75.85 - 75.85
52-Week Range 11.10 - 104.00
Beta 1.57
RSI 18.44
Earnings Date Feb 26, 2026

About Mecure Industries

Mecure Industries PLC manufactures and sells pharmaceuticals in Nigeria. The company also engages in distributing multivitamins products. In addition, it offers antibiotics, antimalarials, antihypertensives, antidiabetics, analgesics and nsaids, proton pump inhibitors, and H2 receptor antagonists. Further, it provides blood tonics; cough, cold, and catarrh preparations; antihistamines; anthelmintic; antacids; steroids; antispasmodics; and antidiarrheals. Additionally, it involved in the contract manufacturing services. It sells its products thr... [Read more]

Industry Pharmaceutical Preparations
Founded 2005
Employees 192
Stock Exchange Nigerian Stock Exchange
Ticker Symbol MECURE
Full Company Profile

Financial Performance

In 2025, Mecure Industries's revenue was 77.69 billion, an increase of 68.80% compared to the previous year's 46.03 billion. Earnings were 6.46 billion, an increase of 177.52%.

Financial Statements

News

There is no news available yet.